Clinical Trial: Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase 2 Double-blinded, Placebo-controlled, Clinical Trial for Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment
Brief Summary: To investigate the safety and efficacy of methylprednisolone infiltration in anserine bursitis treatment
Detailed Summary:
Sponsor: Universidad Autonoma de Nuevo Leon
Current Primary Outcome: WOMAC score [ Time Frame: 4 weeks ]
The WOMAC (Westren Ontario and McMaster Universities) index is used to assess patients with osteoarthritis of the hip or knee using 24 parameters. It can be used to monitor the course of the disease or to determine the effectiveness of anti-rheumatic medications.
Pain, Stiffness and Physical functionVisual analogue scale (VAS) may be used ranging from 0 to 10.
Original Primary Outcome: Same as current
Current Secondary Outcome:
- VAS satisfaction [ Time Frame: 4 weeks ]Visual Analoge Scale for satisfaction
- Improvement [ Time Frame: 4 weeks ]Percentage of improvement
- SAFETY [ Time Frame: 4 weeks ]Pain at infiltration site, ecchymosis, bleeding, paresthesias, skin infection, anaphilaxy, vasovagal reaction
Original Secondary Outcome: Same as current
Information By: Universidad Autonoma de Nuevo Leon
Dates:
Date Received: July 28, 2010
Date Started: September 2009
Date Completion:
Last Updated: September 17, 2010
Last Verified: June 2009